Eli Lilly and Company Limited

Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Customer Care direct line: +44 (0)1256 315 999
Medical Information Fax: +44 (0)1256 775 569
Patient Information Leaflet last updated on the eMC: 25/08/2009
PIL Yentreve 20mg and 40mg hard gastro-resistant capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 22/05/2008 and displayed until 25/08/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 19/09/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to instructions about overdose
  • Introduction of new pack/pack size
  • Change to date of revision
Updated on 10/01/2007 and displayed until 19/09/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/01/2007 and displayed until 10/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
Updated on 03/07/2006 and displayed until 05/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 05/12/2005 and displayed until 03/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 15/11/2005 and displayed until 05/12/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/09/2004 and displayed until 15/11/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   duloxetine hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk